LYRA
Price:
$0.1749
Market Cap:
$11.45M
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase II clinical trial; and LYR-220 for CRS patients with and without nasal polyps. The company was formerly known as 480 Biomedical, Inc. and changed its ...[Read more]
Industry
Biotechnology
IPO Date
2020-05-01
Stock Exchange
NASDAQ
Ticker
LYRA
According to Lyra Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.64. This represents a change of -16.15% compared to the average of 4.34 of the last 4 quarters.
The mean historical Current Ratio of Lyra Therapeutics, Inc. over the last ten years is 7.52. The current 3.64 Current Ratio has changed 4.74% with respect to the historical average. Over the past ten years (40 quarters), LYRA's Current Ratio was at its highest in in the June 2020 quarter at 22.66. The Current Ratio was at its lowest in in the March 2019 quarter at 0.
Average
7.52
Median
6.16
Minimum
1.94
Maximum
15.54
Discovering the peaks and valleys of Lyra Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 700.01%
Maximum Annual Current Ratio = 15.54
Minimum Annual Increase = -84.72%
Minimum Annual Current Ratio = 1.94
Year | Current Ratio | Change |
---|---|---|
2023 | 5.35 | -23.24% |
2022 | 6.97 | 165.33% |
2021 | 2.63 | -83.10% |
2020 | 15.54 | 700.01% |
2019 | 1.94 | -84.72% |
The current Current Ratio of Lyra Therapeutics, Inc. (LYRA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.98
5-year avg
6.49
10-year avg
7.52
Lyra Therapeutics, Inc.’s Current Ratio is greater than CytomX Therapeutics, Inc. (1.04), greater than Assembly Biosciences, Inc. (2.36), less than Achilles Therapeutics plc (6.04), less than Neoleukin Therapeutics, Inc. (15.33), less than Instil Bio, Inc. (12.90), less than NextCure, Inc. (9.07), greater than Spero Therapeutics, Inc. (2.68), less than Nuvation Bio Inc. (9.57), less than Cullinan Oncology, Inc. (24.46), greater than Bolt Biotherapeutics, Inc. (3.16), less than Day One Biopharmaceuticals, Inc. (14.62), less than Autolus Therapeutics plc (13.69),
Company | Current Ratio | Market cap |
---|---|---|
1.04 | $85.30M | |
2.36 | $94.84M | |
6.04 | $40.33M | |
15.33 | $8.20M | |
12.90 | $141.74M | |
9.07 | $26.35M | |
2.68 | $50.31M | |
9.57 | $898.63M | |
24.46 | $691.16M | |
3.16 | $19.56M | |
14.62 | $1.28B | |
13.69 | $580.14M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lyra Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lyra Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Lyra Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Lyra Therapeutics, Inc. (LYRA)?
What is the highest Current Ratio for Lyra Therapeutics, Inc. (LYRA)?
What is the 3-year average Current Ratio for Lyra Therapeutics, Inc. (LYRA)?
What is the 5-year average Current Ratio for Lyra Therapeutics, Inc. (LYRA)?
How does the current Current Ratio for Lyra Therapeutics, Inc. (LYRA) compare to its historical average?